Posted inHealth and FitnessLife

Alzheimer’s Association Welcomes FDA Approval of Aducanumab

On behalf of those impacted by Alzheimer’s disease, the Alzheimer’s Association enthusiastically welcomes today’s historic FDA approval of aducanumab (Biogen/Eisai) for treatment of Alzheimer’s disease. “This approval is a victory for people living with Alzheimer’s and their families,” said Harry Johns, Alzheimer’s Association president and chief executive officer. “This is the first FDA-approved drug that […]

Posted inCORONAVIRUSLocal news

Analysis shows Alzheimer’s disease, dementia deaths up during COVID-19 pandemic

Wisconsin and many other states are dealing with an increase in deaths from Alzheimer’s disease and dementia during the coronavirus pandemic, according to an Alzheimer’s Association analysis of CDC data from 2020. MILWAUKEE ⏤ Wisconsin deaths from Alzheimer’s disease and dementia have increased during the COVID-19 pandemic. However, Wisconsin is not the only state seeing […]